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Abstract During our search for Streptomyces spp. as new producers of bioactive secondary
metabolites, the ethyl acetate extract of the new terrestrial Streptomyces isolate
TN262 delivered eight antimicrobially active compounds. They were identified as 1-
acetyl-β-carboline (1), tryptophol (2), cineromycin B (3), 2,3-dihydrocineromycin B (4),
cyclo-(tyrosylprolyl) (5), 3-(hydroxyacetyl)-indole (6), brevianamide F (7), and cis-cyclo-
(L-prolyl-L-leucyl) (8). Three further metabolites were detected in the unpolar fractions
using GC–MS and tentatively assigned as benzophenone (9), N-butyl-benzenesulfonamide
(10), and hexanedioic acid-bis-(2-ethylhexyl) ester (11). This last compound is known as
plasticizer derivatives, but it has never been described from natural sources. In this article,
we describe the identification of the new Streptomyces sp. isolate TN262 using its cultural
characteristics, the nucleotide sequence of the corresponding 16S rRNA gene and the
phylogenetic analysis, followed by optimization, large-scale fermentation, isolation of the
bioactive constituents, and determination of their structures. The biological activity of
compounds (2), (3), (4), and those of the unpolar fractions was addressed as well.
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The dramatic rise of antibiotic resistance in human pathogenic microorganisms gave good
reasons for the continuous development of novel antibiotics. Filamentous soil bacteria
belonging to the genus Streptomyces are still rich sources of bioactive natural products with
a great functional diversity [1], which are extensively used as pharmaceuticals and
agrochemicals [1–4].
During our search program for bioactive compounds from actinomycetes, a new
terrestrial bacterium was isolated, selected, and identified as Streptomyces sp. TN262 strain,
followed by studies of the influences of different nutritional compounds on the biosynthesis
of its bioactive molecules. The strain exhibited a potent activity against Micrococcus luteus
LB 14110, Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 6538, Salmonella
enterica ATCC43972, and Fusarium sp. Chemical screening of the extract using TLC
displayed the existence of four blue UV fluorescent (366 nm) or absorbing (254 nm) bands,
respectively, besides a major one, which turned dark violet after spraying with
anisaldehyde/sulfuric acid and showed only weak UV absorbance. Upscaling of the strain
at optimum conditions followed by chromatographic separation afforded eight compounds
1–8. Further, components were tentatively assigned by GC–MS analysis of the less polar
fractions I and II as benzophenone (9), N-butyl-benzenesulfonamide (10), and as the
naturally hexanedioic acid-bis(2-ethylhexyl)ester (11).
Materials and Methods
Spectroscopic Measurements
The NMR spectra were measured on a Bruker AMX 300 (300.135 MHz), a Varian Unity
300 (300.145 MHz), and a Varian Inova 600 (150.820 MHz) spectrometer. ESI MS was
recorded on a Finnigan LCQ with quaternary pump Rheos 4000 (Flux Instrument). EI mass
spectra were recorded on a Finnigan MAT 95 spectrometer (70 eV) with perfluorkerosine as
reference substance for EI HRMS. GC–MS was measured on a Trace GC–MS Thermo
Finnigan instument (ionization mode EI, 70 eV), equipped with a capillary column CP-Sil
8 CB for amines (length=30 m; inside diameter=0.25 mm; outside diameter=0.35 mm;
film thickness=0.25 µm). The analysis was carried out at a programmed temperature:
initial temperature 40°C (kept for 1 min), then increasing at a rate of 10°C/min to a final
temperature of 280°C (kept for 10 min). In the EI mode, the injector and detector
temperature was set to 250°C; he was used as carrier gas at flow rate of 1 ml/min, total run
time 27 min, injection volume 0.2 µl. Flash chromatography was carried out on silica gel
(230–400 mesh). Rf values were measured on Polygram SIL G/UV254 (Macherey-Nagel &
Co.). Size exclusion chromatography was done on Sephadex LH-20 (Pharmacia). Optical
rotations were measured on a Perkin–Elmer polarimeter (model 343).
Microorganisms and Plasmids
The chromosomal DNA of the terrestrial Streptomyces sp. isolate TN262 was used to
amplify the 16S rRNA gene. E. coli TOP10 (Invitrogen), F-mcrA Δ(mrr-hsdRMS-mcrBC)
ϕ80lacZΔM15 ΔlacX74 deoR recA1 araD139 Δ(ara-leu)7697 galU galK rpsL endA1
nupG, and E. coli DH5α [1] were used as host strains. Bacterial strains M. luteus LB
14110, S. aureus ATCC 6538, E. coli ATCC 8739, and S. enterica ATCC43972 were used
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determined against a Fusarium sp.
pIJ2925 derivative of pUC18 and pCR-Blunt vector (Invitrogen) Col E1 origin (pUC-
derived) Kn
R were used as the cloning vectors. pLE1 is a derivative of pCR-Blunt vector
carrying a 1.5-kb fragment corresponding to the whole 16S rRNA gene of the TN262
strain (this work). pLE2 and pLE3 are derivatives of pIJ2925 carrying, respectively, the
0.9- and 0.6-kb EcoRI–EcoRI DNA fragments of the 16S RNA gene of the TN262 strain
(this work).
Culture Conditions
E. coli DH5α was grown on Luria–Bertani (LB) plates supplemented with ampicillin
(50 μg/ml) and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (40 μg/ml) when
appropriate [1]. Transformation of E. coli DH5α with pIJ2925 derivatives was carried
out according to Hanahan [5]. Growth and transformation of TOP10 E. coli strain with the
pCR-Blunt vector derivative were carried out according to the manufacturer’s instructions
(Invitrogen). For the isolation of actinomycete strains, soil and water samples collected
from different Tunisian regions were spread on solid boiled bran barley medium [6]: 0.2%
yeast extract and 2% agar were added to a supernatant of 4% boiled bran barley. The pH
was adjusted to 7. After incubation at 30 or 40°C for several days, colonies showing
sporulation and filamentous morphology were picked and propagated on the same solid
medium. For determination of antibacterial activities, indicator microorganisms were grown
overnight in LB medium, M. luteus LB 14110 and S. enterica ATCC43972 at 30°C and
E. coli ATCC 8739 and S. aureus ATCC 6538 at 37°C, then diluted 1:100 in LB medium
and incubated for 5 h under constant agitation (200 rpm) at the appropriate temperature. For
antifungal testing, Fusarium sp. was grown in potato dextrose agar for 7 days at 30°C.
Spores were collected in sterile distilled water and then concentrated to produce a
suspension with approximately 10
4 spores/ml.
The TN262 strain was grown in tryptic soy broth (TSB) at 30 g/l for the preparation of
genomic DNA [1]. Cultural characteristics of TN262 strain were compared on the basis of
observations made after 7, 14, and 21 days incubation on nutrient agar, Sabouraud agar, and
yeast malt agar media [1]. To investigate the influence of the medium on antimicrobial
production, spores at 10
7/ml were used to inoculate 500-ml Erlenmeyer flasks with four
indents, containing 100 ml of TSB medium (30 g/l). After incubation at 30°C for 24 h, this
preculture was used to inoculate at 1/10 (v/v) 1,000-ml Erlenmeyer flasks with four indents,
containing 200 ml of modified Bennett medium (peptone 2 g/l, yeast extract 1 g/l, beef
extract 1 g/l) supplemented at 1% (w/v) with one of the five tested carbon sources (starch,
fructose, glycerol, glucose, and saccharose). After incubation at 30°C for 72 h in an orbital
incubator with shaking at 200 rpm, biological activities were assayed for each culture
supernatant. Influence of magnesium, potassium, and trace mineral oligoelements on active
molecules production was also investigated by addition of these chemical additives to the
culture medium, additive by additive, the combination of two additives, and the addition of
all three additives. The final magnesium and potassium concentration was 2 and 1 mmol/l,
respectively. For trace mineral oligoelements (40 mg ZnCl2, 200 mg FeSO4·7H2O, 6.5 mg
H3BO3, and 13.5 mg MoNa2O4·2H2O per 100 ml distilled water), 1.5 ml were added to
200 ml of growth medium. Eight different concentrations (% w/v) of glycerol were tested:
0.2; 0.5; 0.75; 1; 1.25; 1.5; 1.75; and 2. The effect of culture conditions like different
incubation temperatures (25, 30, 35, and 40°C), initial pH (6, 6.5, 7, 7.2, 7.5, and 8),
incubation times (24, 36, 48, 60, 72, 84, 96, 110, 120, and 144 h), and rotary shaker (100,
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Biomass of the Streptomyces sp. TN262 strain was determined by measuring the dry weight
after drying at 105°C.
DNA Isolation and Manipulation
Total DNA preparation from TN262 strain was carried out according to Hopwood et al. [7].
Small-scale plasmid preparations from E. coli were performed as described by Sambrook et
al. [8]. Digestion with restriction endonucleases, separation of DNA fragments by agarose
gel electrophoresis, dephosphorylation with alkaline calf intestinal phosphatase, ligation of
DNA fragments, and transformation of E. coli were done according to Sambrook et al. [8].
PCR Amplification of the 16S rRNA Gene of TN262 Strain
PCR amplification of the 16S rRNA gene of TN262 strain was performed using two primers 5′-
AGAGTTTGATCCTGGCTCAG-3′ and 5′-AAGGAGGTGATCCAGCCGCA-3′ as described
by Edwards et al. [9]. Approximately 200 ng genomic template DNA was used with 150 pmol
of each primer per 50 μl reaction volume. To improve the denaturation of the DNA, 5% (v/v)
DMSO was added to the reaction mixture. Amplification was performed in an automated
thermocycler (Perkin Elmer) using 1 U Pfu DNA polymerase (Stratagene) and the
recommended buffer system according to the following amplification profile: 94°C (3 min)
f o l l o w e db y4 5c y c l e so fd e n a t u r a t i o na t9 4° C( 3 0s ) ,a n n e a l i n ga t6 0° C( 1m i n ) ,a n de x t e n s i o n
at 72°C (3 min). The PCR reaction mix was analyzed by agarose gel electrophoresis, and the
DNA of the expected size was purified and then cloned into pCR-Blunt vector yielding pLE1.
DNA Sequencing and Analysis
Nucleotide sequence of the 16S rRNA gene of TN262 strain was determined on both
strands by an automated 3100 Genetic Analyzer (Applied Biosystems) using specific
primers. Homology search was performed using BLAST Search algorithm. The nucleotide
sequence of the whole 16S rRNA gene (1,540 bp) of TN262 strain has been assigned
GenBank (EMBL) under accession number FM867598. Multiple sequence alignment was
carried out using clustal W [10] at the European Bioinformatics Institute website (http://
www.ebi.ac.uk/clustalw/). Phylogenetic analyses were performed using programs from the
PHYLIP package [11], and phylogenetic tree was constructed by the neighbor joining (NJ)
algorithm [12] using Kimura 2-parameter distance. The robustness of the inferred tree was
evaluated by bootstrap (100 replication).
Fermentation and Working Up
Spores at 10
7/ml of Streptomyces strain TN262 were used to inoculate 1,000-ml Erlenmeyer
flasks, each containing 200 ml of TSB medium at 30 g/l. After incubation at 30°C for 24 h
in an orbital incubator with shaking at 200 rpm; the preculture was used to inoculate 20 l of
modified Bennett medium, supplemented at 1% (w/v) with glycerol. For this realization, we
have used two fermenters having each one a total capacity of 15 l (working capacity of
10 l). After 3 days fermentation (30°C), the fermenter culture broth was subjected to
filtration over celite using a filter press. The filtrate was exhaustively extracted by ethyl
acetate (2×) and the obtained organic extract concentrated in vacuo to dryness, affording
2.4 g of a reddish brown crude extract.
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The obtained crude extract (2.4 g) was fractionated by Sephadex LH-20 column
chromatography (100×3 cm, DCM/40% MeOH). After TLC monitoring and visualization
by UV light and anisaldehyde/sulfuric-acid-spraying reagent, four fractions were collected.
The middle polar fraction III (600 mg), containing numerous components, was applied to a
silica gel column and afforded three subfractions; IIIa (120 mg), IIIb (270 mg), and IIIc
(150 mg). The subfraction IIIa was further purified using a silica gel column (DCM/40%
MeOH) followed by Sephadex (DCM/40% MeOH) to afford 1-acetyl-β-carboline (1)a sa
faint yellow solid (2.3 mg) and colorless tryptophol (2, 1.9 mg). The major subfraction
IIIb delivered three further components on a silica gel column: The first of them was
further purified on RP-18 (20×1.5 cm, MeOH/H2O) followed by Sephadex LH-20 (MeOH)
to give a colorless solid (21.1 mg) of cineromycin B (3) containing traces of 2,3-
dihydrocineromycin B (4). The remaining two components delivered in a similar way
on Sephadex LH-20 (DCM/40% MeOH) colorless tryptophol (2) and cyclo-(tyrosylprolyl)
(5, 28.7 mg). Similarly, the subfraction IIIc was further purified to afford 3-(hydroxyacetyl)-
indole (6, 5.1 mg) as colorless solid. Finally, the polar fraction IV (400 mg) gave
brevianamide F (7, 2.3 mg) and cis-cyclo-(L-prolyl-L-leucyl) (8, 15.3 mg) as two colorless
solids.
The unpolar two fractions I (250 mg) and II (80 mg) displayed similar TLC profiles and
were combined. Spraying with anisaldehyde/sulfuric acid displayed numerous components,
some of which turned blue. Three components were tentatively assigned by GC–MS
analysis as benzophenone (9), N-butyl-benzenesulfonamide (10), and hexanedioic acid-bis
(2-ethylhexyl)ester (11). Details of the GC–MS conditions were described under the section
of “Spectroscopic Measurements.”
Cineromycin B (3) C17H26O4 (294); colorless solid, turned dark violet by anisaldehyde/
sulfuric acid; Rf=0.26 (CH2Cl2/10% MeOH); [α]D
25 −111 (c=0.1, MeOH);
1H NMR
(300 MHz, CDCl3) and
13C NMR (125 MHz, CDCl3): see Table 1; CI MS (NH3) m/z (%)=
608 ([2 M+NH4]
+, 2), 312 ([M+NH4]
+, 56), 294 ([M-H2O+NH4]
+, 14); (+)-ESI MS m/z
(%)=613 ([2 M+Na]
+, 6), 317 ([M+Na]
+, 49); (+)-HRESI MS m/z 317.17236 ([M+Na]
+,
calcd: 317.17234 for C17H26O4Na).
2,3-Dihydrocineromycin B (4) C17H28O4 (296); colorless solid with same color reaction as 3;
Rf=0.42(CH2Cl2/10% MeOH); CI MS (NH3) m/z (%)=610 ([2 M+NH4]
+, 6), 314 ([M+NH4]
+,
100), 296 ([M-H2O+NH4]
+, 66); (+)-ESI MS m/z (%)=615 ([2 M+Na]
+, 12), 319 ([M+Na]
+,
100); (+)-HRESI MS m/z 319.18798 ([M+Na]
+, calcd: 319.18799 for C17H28O4Na). The NMR
data were identical with recently published values [13].
Antimicrobial Activities
Agar diffusion tests against M. luteus LB 14110, S. aureus ATCC 6538 (Gram-positive
bacteria), E. coli ATCC 8739, S. enterica ATCC43972 (Gram-negative bacteria), and a
Fusarium sp. were used. For the determination of antibacterial activities in solid media,
after incubation of the selected actinomycete strains for 7 days at the appropriate growth
temperature, an agar disk was recuperated and picket in LB plates covered by 3 ml of top
agar containing 50 μl of a 5-h culture of one of the four indicator bacteria. After 2 h at 4°C,
plates containing M. luteus, LB 14110, and S. enterica ATCC43972 were incubated
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were incubated overnight at 37°C. For antifungal activities determination, plates were
covered by 3 ml of top agar containing 50 µl of spore suspension prepared from the
Fusarium sp. After 2 h at 4°C, plates were incubated at 30°C for 48 h. For the
determination of the antimicrobial activities from liquid media, a paper disk was
impregnated with 50 μl of the corresponding sample and then laid on the surface of an
agar plate containing 3 ml of top agar inseeded with the indicator microorganism using the
same conditions as for the solid medium analysis. The antimicrobial activities of the pure
compounds were determined against the same indicator cells under the same conditions as
those from liquid media. Plates were examined for antimicrobial activities represented by
an inhibition zone of the corresponding indicator microorganisms.
Results and Discussion
Isolation, Identification, and Phylogenetic Analysis of TN262 Strain
A new actinomycete strain isolate TN262 was obtained from south Tunisian soil, exhibiting
antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi
(Fig. 1). Strain TN262 grew well in nutrient agar medium (Table 2), and the colors of
the vegetative and aerial mycelia were yellowish and grayish, respectively. The spore
chains were grayish-yellow. Comparison of these characteristics with those of actinomycete
species described in Bergey’s manual of systematic bacteriology [14] suggested that TN262
strain belongs to the genus Streptomyces. Total nucleotide sequence of 1,540 bp (accession
no. FM867598), of the whole 16S rRNA gene of the TN262 strain was determined in both
Table 1
13C and
1H NMR data (CDCl3, J in Hz) of Cineromycin B (3), compared with literature values.
No. Cineromycin B (3), exp. Cineromycin B (3), lit. [23]
δC δH δC δH
1 166.1 – 166.3 –
2 115.1 5.87 (d, 15.5) 115.0 5.86 (d, 16)
3 155.2 6.93 (d, 15.5) 155.5 6.91 (d, 16)
4 73.4 – 73.4 –
5 135.2 5.87 (d, 15.5) 135.3 5.85 (d, 16)
6 133.6 5.73 (dd, 16.3, 4.8) 133.6 5.71 (dd, 16, 5)
7 74.6 4.55 (m) 74.5 4.53 (d, 5)
8 137.9 – 137.9 –
9 129.5 5.23 (m) 129.4 5.21 (brm)
10 25.1 2.10 (m), 1.80 (m) 25.0 2.10 (brm), 1.84 (d, 16.5)
11 34.8 1.21 (m), 1.16(m) 34.3 1.22 (m), 1.17 (m)
12 39.5 1.25 (m) 39.5 1.40 (brq, 6)
13 75.5 4.55 (m) 75.6 4.55 (d, 7)
CH3-4 27.1 1.55 (s) 27.0 1.53 (s)
CH3-8 15.0 1.73 (s) 15.0 1.71 (s)
CH3-12 16.1 0.89 (d, 6.6) 16.1 0.88 (d, 6)
CH3-13 18.2 1.22 (d, 6.3) 18.1 1.21 (d, 7)
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sequences in gene bank shows high similarity (97–98%) to the Streptomyces 16S rRNA
genes. The organism most similar to the new isolate TN262 strain was Streptomyces
flavogriseus AJ494864 (Fig. 2), which had been described as a cellulolytic activity
producer [15]. Based on the cultural characteristics of TN262 and the nucleotide sequence
of the corresponding 16S rRNA gene and the phylogenetic analysis, we propose the
assignment of our new isolate bacterium as Streptomyces sp. TN262 strain.
Optimization of Nutritional and Cultural Conditions
Production of secondary metabolites by microorganisms is often connected with and
influenced by primary metabolism. The composition and concentrations of the constituents
of the media are closely linked with the metabolic capacities of the producing organism and
greatly influence the biosynthesis of the bioactive molecules. Equally, the effect of other
factors including medium volume, oxygen transfer rate, temperature, initial pH of the
medium, and incubation time on secondary metabolites production were frequently reported
[4].
Nutritional Conditions
Five carbohydrate sources (starch, fructose, glycerol, glucose, and saccharose) were tested as
sole carbon source at 1% (w/v) in the modified Bennett liquid medium. The studied strain
exhibited the ability to grow on all tested carbon sources. The maximum biological activity
production was afforded when glycerol served as carbon source. To further optimize the
culture conditions, three compounds (potassium, magnesium, and trace mineral oligoelements)
were tested using glycerol at 1% (w/v) as carbon source. These chemicals were added to the
culture medium, additive by additive, by the combination of two additives, and by addition of
all three additives. A culture without chemical additives was used as control. The obtained
results showed that maximal antimicrobial activities against the five test microorganisms were
observed with the control culture. It was noticed that the addition of these chemical
compounds did not alter the bioactive molecules production.
A1 A2 A3  B1  B2  B3  B4  B5
Fig. 1 Antimicrobial activities of TN262 strain in solid media against M. luteus LB 14110 (A1), E. coli
ATCC 8739 (A2), and Fusarium sp. (A3), and in liquid media against: M. luteus LB 14110 (B1), S. aureus
ATCC 6538 (B2), E. coli ATCC 8739 (B3), S. enterica ATCC43972 (B4), and Fusarium sp. (B5)
Table 2 Cultural characteristics of TN262 strain.
Medium Growth Vegetative mycelia Aerial mycelia Spores
Nutrient agar Well, spreading Abundant, yellowish Abundant, grayish Moderate, grayish-
yellow
Sabouraud agar Weak Weak, yellowish Weak, yellowish Weak, elevated,
yellowish
Yeast malt agar Moderate Detachable, yellowish Moderate, grayish-brown Moderate, brown
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The effect of culture conditions, namely incubation temperature (25–40°C), initial pH (6–8),
incubation time (24–144 h), and rotary shaker speed (100–300 rpm) on growth and
Streptomyces flavogriseusAJ494864
Streptomyces sp.TN262
Streptomyces sp.EU119202-1
Streptomyces sp.AF429398 1
Streptomyces sp.AF429395 1
Streptomyces sp.AF429390 1
Streptomyces sp.AF389344
Streptomyces sp.AF429392
Streptomyces sp.AF221837
Streptomyces sp.AF429396
Streptomyces sp.AF429391
Streptomyces sp.AF429399
10
8
19
67
Streptomyces sp.EU080951 1
Streptomyces sp.EU080953-1
58
Streptomyces sp.EU080967-1
Streptomyces setoniiD63872
Streptomyces sp.EU080971-1
Streptomyces sp.EU080944
7
6
14
22
Streptomyces sp.EU080954
Streptomyces griseusAB030572
Streptomyces sp.EU080970 1
60
15
46
17
57
28
17
19
42
100
Fig. 2 Phylogenetic tree of the Streptomyces sp. isolate TN262 strain
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range of incubation temperature for good growth and active molecules production. The
optimum temperature was 30°C. The studied strain appeared to be mesophilic. The highest
antimicrobial activities against the five tested microorganisms were obtained at an initial pH 7
of the culture medium. Concerning incubation time, antimicrobial activities appeared to be
pronounced after 36 h of growth with a maximum at 72 h of incubation. This activity
remained stable between 72 and 96 h and then decreased and disappeared after 140 h of
incubation. For Streptomyces sp. TN262, agitation rates of 100, 150, and 300 rpm gave a low
production of active molecules, while the best result was noticed at 200 and 250 rpm.
To further enhance the antibiotic production by Streptomyces sp. TN262, we have
investigated the effect of the glycerol concentration. Eight concentrations (% w/v)w e r et e s t e d
(0.2, 0.5, 0.75, 1, 1.25, 1.5, 1.75, and 2.0). Eight flasks, each containing 200 ml broth, were
inoculated at 5% (v/v) with a 24-h preculture of Streptomyces TN262 prepared in TSB
medium (10
7/ml of spores). After 3 days of incubation, the obtained broths were harvested.
Biomass of mycelium of each culture was determined after drying at 105°C, and the
supernatants were exhaustively extracted with ethyl acetate, and the extracts concentrated in
vacuo to dryness and then dissolved in 250 μl of ethyl acetate. Thereafter, the extracts were
examined for their antimicrobial activity against bacteria and fungi (Fig. 3). In summary, the
biological activities were correlated with biomass production. This biomass increased with
increasing glycerol concentrations up to 0.75% (w/v) and remained nearly constant up to
1.25% (w/v) with a maximum at 1% (w/v). Any further increase of this substrate level resulted
in a decrease in biomass and consequently in active molecules production. The same
observation has been reported by Fourati et al. [16] for the antifungal compounds produced
by Streptomyces sp. US80. In that case, the biomass increased with increasing glucose
concentration (carbon source) and magnesium (chemical additive which influence positively
the antifungal compounds production) concentration up to 5 g/l and 3.5 mM, respectively.
Isolation and Structural Elucidation of the Active Constituents
Structures of the isolated compounds were elucidated as:
*1-acetyl-β-carboline [17, 18]( 1). This compound has been reported as plant
metabolite [17] and from Streptomyces bacteria [18]. β-carboline derivatives were
reported as herbicidal and fungicidal agents.
*tryptophol [19–21]( 2), a well-known constituent of terrestrial plants and micro-
organisms, has so far been isolated from tryptophan fermentations, plant seedlings,
Aspergillus niger, fungi Balansia epichloe, Dreschslera nodulosum, Agrobacterium
tumefaciens, Ceratocystis spp., Rhizobium spp., marine sponge Ircinia spinulosa, etc.
This molecule was reported to have antibacterial activity against Gram-positive
bacteria and Candida albicans [19].
*cineromycin B [13, 22, 23]( 3) and 2,3-dihydrocineromycin B [13, 24]( 4). These two
active molecules have been already described from Streptomyces species, as two 14-
membered ring macrolide antibiotics. Most macrolides are produced by Streptomyces
species, and these compounds are mainly bioactive against Gram-positive bacteria by the
inhibition of their protein synthesis by binding to the 50s subunits of 70s ribosomes.
*3-(hydroxyacetyl)-indole [20, 25]( 5) has been reported from the marine red alga
Prionitis lanceolata, fungus Lactarius deliciosus, and a terrestrial Streptomyces sp.
bacterium [20]. The compound was found to inhibit the growth of a minipanel of
human cancer cell lines and P388 lymphocytic leukemia cells.
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molecules constitute a family of secondary metabolites with diverse and interesting
biological activities such as antibacterial, fungicidal, herbicidal, immunosuppressor,
antitumors, and antiviral [20]. This compound was previously described from
Pseudomonas aeruginosa and some Streptomyces strains.
*brevianamide F [20, 27]( 7) and cis-cyclo-L-prolyl-L-leucyl [20, 28, 29]( 8) using 1D
and 2D NMR spectra, mass spectrometry, and by comparison with the literature.
Brevianamide F is a tryptophan–proline derivative. Prolinated indole derivatives:
tryprostatins, cyclotryprostatins, spirotryprostatins, fumitremorgins, verruculogen,
austamides, paraherquamides, and brevianamides are a large class of alkaloids
containing a tryptophan moiety substituted with isoprenic moieties and are mostly
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concentration on the growth,
productivity, and antimicrobial
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588 Appl Biochem Biotechnol (2010) 162:579–593found in fungi of the genera Aspergillus and Penicillium [20]. Compound (8), the
cis-cyclo-L-prolyl-L-leucyl, is a DKP derivative.
The complex mixtures present in the unpolar fractions I and II were analyzed by GC–MS, and
benzophenone [30]( 9), N-butyl-benzenesulfonamide [31]( 10), and the natural product
hexanedioic acid-bis-(2-ethylhexyl)ester (11) were identified by comparison with the NIST MS
database (Table 3). Benzophenone (9) is an important intermediate in the production of medicines
and cosmetics but is also known as a xenoestrogen in its effect on mammals. This molecule has
been produced by chemical synthesis and previously isolated from the plant Tovomita longifolia
and the sea Streptomyces bacterium GWS-BW-H5 [30]. N-butyl-benzenesulfonamide (10)
exhibits antifungal activities and has been described from the bacterium Pseudomonas sp.
AB2 [31]. The hexanedioic acid-bis-(2-ethylhexyl)ester compound (11) is known as
plasticizer derivatives [32–34], but it has never been described from natural sources.
Cineromycin B
Compound 3, a colorless solid, was obtained from fraction 3 after a series of chromatographic
steps including separation on RP-18. It was a weakly UV absorbing substance, exhibiting a
dark violet coloration on spraying with anisaldehyde/sulfuric acid. The molecular weight of 3
was established as 294 Da according to CI MS and ESI MS, and the corresponding molecular
formula was deduced as C17H26O4 by HRESI MS. This delivered five double-bond
equivalents in 3.
Table 3 GC–MS analysis of the combined unpolar fractions I and II.
Name Rt (min) Relative abundance (%) M. F. M.Wt.
Benzophenone (9) 16.67 17.2 C13H10O 182
N-Butyl-benzenesulfonamide (10) 18.32 60.2 C10H15 NO2S 213
Hexanedioic acid-bis(2-ethylhexyl)ester (11) 23.84 100 C22H42O4 370
OO
OH
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C H3
CH3
C H3
CH3
1
2
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7
9
12
13
Fig. 4 HMBC (right arrow),
and H,H COSY (thick line,
left–right arrow) connectivities
of Cineromycin B (3)
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1H NMR spectrum of 3 revealed the existence of five olefinic protons, among them
four signals of trans-double bonds (d, J~15.5) located in the region δ 6.93–5.23. This
confirmed the existence of three double bonds in the molecule. Moreover, four methyls
were visible, two of them gave singlets (δ 1.73, 1.55), while the others appeared as doublets
(δ 1.22, 0.89, J~6.Hz). Twooxygenated methines wereobserved as multiplets at δ 4.55, along
with other five multiplet signals in the region of δ 1.80~1.21, corresponding to two
methylenes and one methine. Based on the
13C NMR/HMQC spectra (Table 1), compound 3
entailed 17 carbon signals (as requested by the molecular formula), one carbonyl of an ester
or acid (C-1, δ 166.1), and six olefinic carbons, among them five methines (δ 155.2~115.1)
and one quaternary signal (C-8, δ 137.9). In the aliphatic region, there were three oxygenated
carbons, two methines (δ 75.5 and 74.6), and a quaternary one (C-4) at δ 73.4. The remaining
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590 Appl Biochem Biotechnol (2010) 162:579–593seven carbons were attributed to four methyls (δ 27.1~15.0), two non-oxygenated methylenes
(δ 34.2, 25.1), and one methine (C-12, δ 39.5).
Based on the revealed NMR and MS data and the molecular formula, a search in
AntiBase [35], the Dictionary of Natural Products [36], and the Chemical Abstract, referred
to cineromycin B (3) as the only fitting structure.
The compound was further confirmed by HMBC and H–H COSY experiments (Fig. 4).
In accordance, the two olefinic protons H-2 (5.87, δC=115.1) and H-3 (6.93, δC=155.2)
showed
2J and
3J couplings, respectively, with the lactone carbonyl C-1 (δ 166.1),
confirming their direct attachment as ―CH═CH―COO. The two olefinic protons
displayed further two cross signals with the quaternary oxy-carbon C-4 (δ 73.4), which in
turn was connected to a methyl singlet (4-CH3) located at δ 1.55 (δC=27.1) and an olefinic
methine carbon (C-5; δ 135.2, δH 5.87) on the other side. The latter connection (C4–C5) was
further established by a
3J correlation directing from 4-CH3 towards C-5. Additionally, the
C-5 methine gave an H–H COSY cross signal with H-6 (5.73, δC=133.6). To the latter
(C-6), a
2J coupling was found via the oxygenated H-7 (4.55, δC=74.6) and vice versa,
confirming their direct attachment. A methyl group (1.73, δC=15.0) was connected with a
further olefinic double bond, as the
2J coupling with C-8 (137.9) showed; the methine
partner (C-9) was found at δ 5.23 (129.5). At the other side, C-8 is attached to C-7 (δH=
4.55, δC=74.6) as indicated by a cross signal from H-7 to C-8 and C-9. Finally, the
remaining six carbons, two methylenes and two CH-Me fragments, were confirmed to
connect the last olefinic carbon C-9 (129.5) and the lactonic carbonyl (C-1, 166.1),
resulting in the structure of cineromycin B (3) (Fig. 5). This was further confirmed by
comparison with recently published data [23] (Table 1).
2,3-Dihydrocineromycin B
Compound 4 was obtained in a similar way as for 3 as colorless solid, revealing the same
chromatographic color reaction. The molecular weight of 4 was determined as 296 Da by
CI and ESI MS, i.e., 2 amu higher than 3, corresponding to a reduction of one of the three
olefinic double bonds present in 3. The corresponding molecular formula (C17H28O4)o f4
was established by HRESI MS, indicating four equivalent bonds. The
1H NMR spectra of
Table 4 The antimicrobial activity of the unpolar fractions (UnF) and the isolated compounds 2, 3 and 4.
Compound Test microorganism (inhibition zones (mm))
Fusarium sp. M. luteus
LB 14110
S. aureus
ATCC 6538
E. coli
ATCC 8739
S. enterica
ATCC 43972
UnF (20 µg/disk) –– – – –
UnF (30 µg/disk) –– – – –
UnF (40 µg/disk) 15 16 15 ––
UnF (50 µg/disk) 18 20 17 ––
2 (30 µg/disk) 12 19 17 – 12
3, 4 (30 µg/disk) – 13 12 ––
For each concentration and indicator microorganism, the experiment was carried out simultaneously three
times under same conditions. The obtained diameters of inhibition zones were quite similar and the reported
inhibition zones (mm) are the average of the three experiments
ND activity not detected
Appl Biochem Biotechnol (2010) 162:579–593 5914 showed a similar pattern as for 3, with exception of the olefinic H-2 and H-3 signals in 4
(δ 5.87, 6.93). This pointed to the reduction of the double bond in conjugation with the
lactone carbonyl, delivering two methylene groups appearing between δ 2.43~1.80.
Correspondingly, the lactone carbonyl was shifted downfield shifted to δ 174.0 [13]. So,
structure of 4 was established as 2,3-dihydrocineromycin B, an isomer of the alternative
5,6-dihydrocinermycin-B (Fig. 5)[ 13, 24].
Biological Activity of the Isolated Constituents
As shown in Table 4, the unpolar mixture of fractions I and II showed no antimicrobial
activity at concentrations of 20 and 30 μg/disk, while at concentration of 40 μg/disk, potent
activities against Fusarium sp., M. luteus LB 14110, and S. aureus ATCC 6538 were
shown; no inhibitory activities against E. coli ATCC 8739 and S. enterica ATCC43972
(Gram-negative bacteria) were displayed. Biological activity of Tryptophol (2) is more
important against M. luteus LB 14110 and S. aureus ATCC 6538 than against Fusarium sp.
and S. enterica ATCC43972. Cineromycin B (3) and its dihydro-analog (4) showed weak
activity against Gram-positive bacteria [24].
Conclusions
A new aerobic bacterium TN262 was isolated from Tunisian soil and has been selected for
its antimicrobial activity against Gram-positive and Gram-negative bacteria and fungi.
Based on the results of the cultural characteristic studies, analysis of the nucleotide
sequence (1,540 pb) of the whole 16S rRNA gene (accession no. FM867598) of the TN262
strain and the phylogenetic analysis, this isolate has been assigned as Streptomyces sp.
TN262 strain. Addition of glycerol (at 1%, w/v) as carbon source in modified Bennett liquid
medium (72 h, 30°C, 250 rpm) yielded the highest antimicrobial activity. A large-scale
fermentation lead to isolation of eight components, among them two macrolides,
cineromycin B (3), and 2,3-dihydrocineromycin B (4). Their structures were established
by our spectroscopic techniques and comparison with reference data. It should be noted that
in the active supernatant of the TN262 culture, three further metabolites were detected in
the unpolar fractions using GC–MS and tentatively assigned as benzophenone (9), N-butyl-
benzenesulfonamide (10), and hexanedioic acid-bis-(2-ethylhexyl) ester (11). This last
compound is known as plasticizer derivatives [32–34], but it has never been described from
natural sources.
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